Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Repare Therapeutics Inc. (RPTX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K10-K10-KS-1/AS-1/A
Revenues  0.00.00.012.86.2
            Revenue growth    -100.0%107.6% 
Cost of goods sold  0.00.00.012.86.2
Gross profit  0.00.00.00.00.0
            Gross margin     0.0%0.0%
Selling, general and administrative   [+]116.354.426.42.91.8
Other operating expenses  -7.70.71.39.94.4
EBIT   [+]-108.5-55.2-27.7-12.8-6.2
            EBIT margin     -100.0%-100.0%
Interest income  0.30.2   
Other income (expense), net   [+]-0.30.20.6-1.4-1.6
Pre-tax income  -108.6-54.7-27.0-14.2-7.8
Income taxes  -1.7-1.30.20.00.0
            Tax rate  1.5%2.4% 0.2%0.0%
Net income  0.00.00.00.00.0
            Net margin     0.0%0.0%
   
Basic EPS  $0.00$0.00$0.00  
Diluted EPS  $0.00$0.00$0.00  
   
Shares outstanding (basic)   [+]37.820.01.5  
Shares outstanding (diluted)   [+]37.820.01.5  
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy